- This just in July 30
Pharmaceutical giant Pfizer Inc. agreed Wednesday to buy the vaccines unit of Baxter International Inc. in a $635 million deal, Reuters reports.
Through the acquisition, Pfizer will have access to Baxter's meningitis vaccine and its encephalitis vaccine, both of which are currently available outside of the United States. Pfizer will also gain access to part of Baxter's vaccine production facility in Austria.
Pfizer's global vaccines business reported sales of $1.1 billion in the second quarter, while Baxter's international vaccines sales totaled $110 million in the same timeframe. The deal is expected to close by the end of the year.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- How our botched understanding of 'science' ruins everything
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- Save the world... by changing how you pee
- 43 TV shows to watch in 2014
- Why does Fareed Zakaria still have a job?
- Does solar energy have a battery problem?
- The science of sex: 4 harsh truths about dating and mating
- 6 things the happiest families all have in common
- 10 things you need to know today: September 22, 2014
- How to be a moral internet citizen on the often-immoral internet
Subscribe to the Week